Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
The DOI matches its Crossref record; 261 of the 261 references it cites were found in a registry or an index.
Abstract
The adult skeleton regenerates by temporary cellular structures that comprise teams of juxtaposed osteoclasts and osteoblasts and replace periodically old bone with new.A considerable body of evidence accumulated during the last decade has shown that the rate of genesis of these two highly specialized cell types, as well as the prevalence of their apoptosis, is essential for the maintenance of bone homeostasis; and that common metabolic bone disorders such as osteoporosis result largely from a derangement in the birth or death of these cells.The purpose of this article is 3-fold: 1) to review the role and the molecular mechanism of action of regulatory molecules, such as cytokines and hormones, in osteoclast and osteoblast birth and apoptosis; 2) to review the evidence for the contribution of changes in bone cell birth or death to the pathogenesis of the most common forms of osteoporosis; and 3) to highlight the implications of bone cell birth and death for a better understanding of the mechanism of action and efficacy of present and future pharmacotherapeutic agents for osteoporosis.(Endocrine Reviews 21: 115-137, 2000) I. Introduction II.Physiological Bone Regeneration A. Remodeling by the basic multicellular unit (BMU) III.Osteoblastogenesis and Osteoclastogenesis A. Growth factors and their antagonists B. Cytokines C. Systemic hormones D. Adhesion molecules IV.Reciprocal Relationship Between Osteoblastogenesis and Adipogenesis V. Serial and Parallel Models of Osteoblast and Osteoclast Development VI. Function of the Mature Cells A. Osteoblasts B. Osteocytes C. Lining cells D. Osteoclasts VII.Death of Bone Cells by Apoptosis VIII.Regulation of Bone Cell Proliferation and Activity IX.Pathogenesis of Osteoporosis A. Sex steroid deficiency B. Senescence C. Glucocorticoid excess X.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052 · cited 1×
“Long before these cells could be cultured, the existence of multipotent mesenchymal stem cells was suspected (19), based on the evidence that fibroblastic colonies formed in cultures of adherent bone marrow cells can differentiate, under the appropriate stimuli, into each of the above mentioned cells; these progenitor…”
BackgroundOsteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595 · cited 1×
“The most common are chronic glucocorticoid excess (5), particularly its iatrogenic form, hyperthyroidism as well as inappropriately high T replacement, alcoholism, prolonged immobilization, gastrointestinal disorders, hyper-calciuria, some types of malignancy, and cigarette smoking (6).”
BackgroundStimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Research works printed but not linked: 12
- Parfitt, 1992, The two-stage concept of bone loss revisited., Triangle, 31, 99
- Owen, 1985, Lineage of osteogenic cells and their relationship to the stromal system. In: Peck WA (ed) Bone and Mineral Research., Elsevier, Amsterdam, vol, 3, 1
- Franchimont, 1995, Platelet-derived growth factor stimulates the synthesis of interleukin-6 in cells of the osteoblast lineage., Endocrinology, 136, 5469, 10.1210/endo.136.12.7588297 · doi:10.1210/endo.136.12.7588297
- Bianco, 1993, Marrow stromal (Western-Bainton) cells: identification, morphometry, confocal imaging and changes in disease., Bone, 14, 315, 10.1016/8756-3282(93)90158-7 · doi:10.1016/8756-3282(93)90158-7
- Parfitt, 1990, Bone-forming cells in clinical conditions. In: Hall BK (ed) Bone. The Osteoblast and Osteocyte., Telford Press and CRC Press, Boca Raton, FL, vol, 1, 351
- Siddiqi, 1999, Serum cytokines in thyrotoxicosis, J Clin Endocrinol Metab, 84, 435
- Riggs, 1998, Unitary model of osteoporosis revisited., J Bone Miner Res, 13, 1954, 10.1359/jbmr.1998.13.12.1955 · doi:10.1359/jbmr.1998.13.12.1955
- Canalis, 1998, Inhibitory actions of glucocorticoids on skeletal growth. Is local insulin-like growth factor I to blame?, Endocrinology, 139, 3041, 10.1210/endo.139.7.6169 · doi:10.1210/endo.139.7.6169
- Reeve, 1976, Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis., Lancet, 1, 1035, 10.1016/S0140-6736(76)92216-9 · doi:10.1016/s0140-6736(76)92216-9
- Stewart, 1996, PTHrP(1–36) as a skeletal anabolic agent for the treatment of osteoporosis., Bone, 19, 303, 10.1016/S8756-3282(96)00221-9 · DOI
- VanderKuur, 1993, Effects of estradiol-17β analogues on activation of estrogen response element regulated chloramphenicol acetyltransferase expression., Biochemistry, 32, 7016, 10.1021/bi00078a029 · DOI
- Christman, 1995, Relationship between estrogen structure and conformational changes in estrogen receptor/DNA complexes, J Steroid Biochem Mol Biol, 54, 201, 10.1016/0960-0760(95)00137-O · doi:10.1016/0960-0760(95)00137-o
Cited by
Items 101–179 of 179
Energy Metabolism in Mesenchymal Stem Cells During Osteogenic Differentiation
Shum, L. C., White, N. S., Mills, B. N., de Mesy Bentley, K. L., & Eliseev, R. A. (2016) · Stem Cells and Development · doi:10.1089/scd.2015.0193 · Cited by 281
Shay, J., Elbaz, H. A., Lee, I., Zielske, S. P., Malek, M. H., & Hüttemann, M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/181260 · Cited by 279
Kim, S., Koga, T., Isobe, M., Kern, B. E., Yokochi, T., Chin, Y. E., Karsenty, G., Taniguchi, T., & Takayanagi, H. (2003) · Genes & Development · doi:10.1101/gad.1119303 · Cited by 278
Oxygen isotopes in bioarchaeology: Principles and applications, challenges and opportunities
Pederzani, S., & Britton, K. (2019) · Earth-Science Reviews · doi:10.1016/j.earscirev.2018.11.005 · Cited by 278
Basis of bone metabolism around dental implants during osseointegration and peri‐implant bone loss
Insua, A., Monje, A., Wang, H., & Miron, R. J. (2017) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36060 · Cited by 277
Fibroblast growth factor signaling controlling osteoblast differentiation
Marie, P. J. (2003) · Gene · doi:10.1016/s0378-1119(03)00748-0 · Cited by 274
Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs
Plotkin, L. I., Mathov, I., Aguirre, J. I., Parfitt, A. M., Manolagas, S. C., & Bellido, T. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00278.2004 · Cited by 273
Self-citationCaspase-independent cell death?
Lockshin, R. A., & Zakeri, Z. (2004) · Oncogene · doi:10.1038/sj.onc.1207514 · Cited by 270
FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation
Bartell, S. M., Kim, H.-N., Ambrogini, E., Han, L., Iyer, S., Serra Ucer, S., Rabinovitch, P., Jilka, R. L., Weinstein, R. S., Zhao, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms4773 · Cited by 270
Self-citationOsteocyte: the unrecognized side of bone tissue
Rochefort, G. Y., Pallu, S., & Benhamou, C. L. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1194-5 · Cited by 268
“Moreover, dying osteocytes serve as initiators of targeted bone remodeling in response to physiologic or excessive strain to prevent the accumulation of micro-damages [6].”
Geoffroy, V., Kneissel, M., Fournier, B., Boyde, A., & Matthias, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6222-6233.2002 · Cited by 267
Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics
Chandra, A., & Rajawat, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073553 · Cited by 264
Bhattarai, D. P., Aguilar, L. E., Park, C. H., & Kim, C. S. (2018) · Membranes · doi:10.3390/membranes8030062 · Cited by 261
Age-Related Bone Loss: Old Bone, New Facts
Chan, G. K., & Duque, G. (2002) · Gerontology · doi:10.1159/000048929 · Cited by 260
Weitzmann, M. N. (2013) · Scientifica · doi:10.1155/2013/125705 · Cited by 259
Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00097 · Cited by 258
Lüscher, B., Bütepage, M., Eckei, L., Krieg, S., Verheugd, P., & Shilton, B. H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00122 · Cited by 255
Bone Turnover in Prolonged Critical Illness: Effect of Vitamin D
Van den Berghe, G., Van Roosbroeck, D., Vanhove, P., Wouters, P. J., De Pourcq, L., & Bouillon, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030358 · Cited by 252
Estrogen receptor-α signaling in osteoblast progenitors stimulates cortical bone accrual
Almeida, M., Iyer, S., Martin-Millan, M., Bartell, S. M., Han, L., Ambrogini, E., Onal, M., Xiong, J., Weinstein, R. S., Jilka, R. L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65910 · Cited by 252
Self-citationVega, D., Maalouf, N. M., & Sakhaee, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0646 · Cited by 246
Regulation of circulating sclerostin levels by sex steroids in women and in men
Mödder, U. I., Clowes, J. A., Hoey, K., Peterson, J. M., McCready, L., Oursler, M. J., Riggs, B. L., & Khosla, S. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.128 · Cited by 229
“Thus, at the cellular level, E is important for the maintenance of bone formation in part due to a reduction in osteoblast apoptosis.((7))”
BackgroundClarke, B. L., & Khosla, S. (2010) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2010.02.014 · Cited by 221
Seeman, E. (2003) · Osteoporosis International · doi:10.1007/s00198-002-1340-9 · Cited by 220
“The BMU balance is more negative because estrogen deficiency increases the lifespan of osteoclasts so more bone is resorbed in the BMU, while the lifespan of osteoblasts decreases so less bone is formed as well [23, 24].”
BackgroundWattel, A., Kamel, S., Mentaverri, R., Lorget, F., Prouillet, C., Petit, J.-P., Fardelonne, P., & Brazier, M. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01445-4 · Cited by 219
Stossi, F., Barnett, D. H., Frasor, J., Komm, B., Lyttle, C. R., & Katzenellenbogen, B. S. (2004) · Endocrinology · doi:10.1210/en.2003-1682 · Cited by 219
Plotkin, L. I., Lezcano, V., Thostenson, J., Weinstein, R. S., Manolagas, S. C., & Bellido, T. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080617 · Cited by 214
“osteoporotic efficacy of both anabolic and anti-catabolic stimuli.((31,32)) Thus, inhibition of osteoblast apoptosis contributes to the anabolic effect of intermittent PTH administration.”
BackgroundSelf-citationKotlarczyk, M. P., Lassila, H. C., O’Neil, C. K., D’Amico, F., Enderby, L. T., Witt‐Enderby, P. A., & Balk, J. L. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00956.x · Cited by 212
“This is an important finding because as women transition through menopause, these ratios are known to increase such that osteoclast activity outpaces osteoblast activity leading to bone loss [67].”
BackgroundBenisch, P., Schilling, T., Klein-Hitpass, L., Frey, S. P., Seefried, L., Raaijmakers, N., Krug, M., Regensburger, M., Zeck, S., Schinke, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045142 · Cited by 208
“During the first decades of osteoporosis research the main focus has been the imbalance of bone resorption over bone formation as a consequence of pathologically enhanced osteoclast development and function [4].”
BackgroundInfluentialChen, J.-H., Yip, C. Y. Y., Sone, E. D., & Simmons, C. A. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080750 · Cited by 208
“Here we demonstrated that a subpopulation of early passage VICs has osteogenic potential and forms nodules with molecular, protein, cellular, and mineral features consistent with those formed by osteoblasts in vitro.(29,51) However, the osteogenic potential of cultured VICs dropped significantly after approximately si…”
Suppression of Autophagy in Osteocytes Mimics Skeletal Aging
Onal, M., Piemontese, M., Xiong, J., Wang, Y., Han, L., Ye, S., Komatsu, M., Selig, M., Weinstein, R. S., Zhao, H., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.444190 · Cited by 206
“The adult skeleton is continuously remodeled by teams of osteoclasts, which resorb bone, and teams of osteoblasts, which form new bone (1).”
BackgroundSelf-citationBiology of the basic multicellular unit and the pathophysiology of osteoporosis
Jilka, R. L. (2003) · Medical and Pediatric Oncology · doi:10.1002/mpo.10334 · Cited by 203
Bone remodelling: its local regulation and the emergence of bone fragility
Martin, T. J., & Seeman, E. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.07.006 · Cited by 203
Michael, H., Härkönen, P. L., Väänänen, H. K., & Hentunen, T. A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050803 · Cited by 200
“At the tissue level, E2 suppresses bone turnover and maintains a balance between bone formation and bone resorption.((80)) At the cellular level, E2 increases osteoblast differentiation and function but decreases osteoclast formation and activity.”
BackgroundCooper, M. S., Rabbitt, E. H., Goddard, P. E., Bartlett, W. A., Hewison, M., & Stewart, P. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.979 · Cited by 200
Bone Turnover Mediates Preferential Localization of Prostate Cancer in the Skeleton
Schneider, A., Kalikin, L. M., Mattos, A. C., Keller, E. T., Allen, M. J., Pienta, K. J., & McCauley, L. K. (2005) · Endocrinology · doi:10.1210/en.2004-1211 · Cited by 199
“Immunodeficient mice were administered recombinant human (rh)PTH [1–34] daily for 1 wk before and after intracardiac inoculation of PC-3 cells.”
BackgroundMethodInfluentialVitamin D deficiency in patients with active systemic lupus erythematosus
Borba, V. Z. C., Vieira, J. G. H., Kasamatsu, T., Radominski, S. C., Sato, E. I., & Lazaretti-Castro, M. (2009) · Osteoporosis International · doi:10.1007/s00198-008-0676-1 · Cited by 199
“Cytokines like IL-6 and TNF are involved in the pathogenesis of the bone loss of many diseases states [23].”
Background11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196
Strangers in a Strange Land: Stable Isotope Evidence for Human Migration in the Dakhleh Oasis, Egypt
Dupras, T. L., & Schwarcz, H. P. (2001) · Journal of Archaeological Science · doi:10.1006/jasc.2001.0640 · Cited by 195
Recombinant Human Bone Morphogenetic Protein-2 Accelerates Healing in a Rabbit Ulnar Osteotomy Model
Bouxsein, M. L., Turek, T. J., Blake, C. A., D'Augusta, D., Li, X., Stevens, M., Seeherman, H. J., & Wozney, J. M. (2001) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200108000-00012 · Cited by 192
Requisite roles of Runx2 and Cbfb in skeletal development.
Komori, T. (2003) · PubMed · doi:10.1007/s00774-002-0408-0 · Cited by 192
“Receptor activator of nuclear factor-kB ligand (RANKL) expression was decreased, probably through acceleration of osteoblast differentiation at the early stage, because osteoprogenitor cells seem to have more potential to support osteoclast development than more differentiated cells [19].”
BackgroundOsteocytic Canalicular Networks: Morphological Implications for Altered Mechanosensitivity
Milovanovic, P., Zimmermann, E. A., Hahn, M., Djonic, D., Püschel, K., Djuric, M., Amling, M., & Busse, B. (2013) · ACS Nano · doi:10.1021/nn401360u · Cited by 185
Nishikawa, K., Nakashima, T., Takeda, S., Isogai, M., Hamada, M., Kimura, A., Kodama, T., Yamaguchi, A., Owen, M. J., Takahashi, S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42528 · Cited by 180
Exposure of KS483 Cells to Estrogen Enhances Osteogenesis and Inhibits Adipogenesis
Dang, Z. C., Van Bezooijen, R. L., Karperien, M., Papapoulos, S. E., & Löwik, C. W. G. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.3.394 · Cited by 179
“PPAR 2 suppresses the expression of Cbfa1 mRNA and plays a hierarchically dominant role.((46,47)) The increase in osteoblasts observed in our KS483 cells and mouse bone marrow cells therefore could be caused by a duel effect of E2, namely, an enhancement of Cbfa1 and an inhibition of PPAR 2 mRNA expression.”
BackgroundRegulation of bone formation and remodeling by G-protein-coupled receptor 48
Luo, J., Zhou, W., Zhou, X., Li, D., Weng, J., Yi, Z., Cho, S. G., Li, C., Yi, T., Wu, X., et al. (2009) · Development · doi:10.1242/dev.033571 · Cited by 178
The Bone Remodeling Compartment: A Circulatory Function for Bone Lining Cells
Parfitt, A. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.9.1583 · Cited by 169
Kohli, S., & Kohli, V. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.83401 · Cited by 167
“However, there is one finding which overshadows all these accomplishments, which is the recognition and categorization and significance of the RANKL–RANK/ OPG system in bone biology[12] [Figure 1].”
BackgroundHistone Deacetylases in Bone Development and Skeletal Disorders
Bradley, E. W., Carpio, L. R., van Wijnen, A. J., McGee-Lawrence, M. E., & Westendorf, J. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00004.2015 · Cited by 162
Cannabinoid receptors and the regulation of bone mass
Bab, I., & Zimmer, A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707593 · Cited by 161
“of local, autocrine/paracrine and systemic endocrine (Manolagas, 2000).”
BackgroundStatins and osteoporosis: new role for old drugs
Jadhav, S. B., & Jain, G. K. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.1.0002 · Cited by 159
“…of bone formation, various growth factors, like fibroblast growth factor-1 (FGF-1) (Fromigue et al 2004), and transcription factors, like core binding factor (cbfa1) (Karsenty 2000; Komori et al 2000), play a critical role in the proliferation and differentiation of osteoblasts (Manolagas 2000).”
BackgroundCharacterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood
Sørensen, M. G., Henriksen, K., Schaller, S., Henriksen, D. B., Nielsen, F. C., Dziegiel, M. H., & Karsdal, M. A. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0725-9 · Cited by 143
Ablation of the Sam68 RNA Binding Protein Protects Mice from Age-Related Bone Loss
Richard, S., Torabi, N., Franco, G. V., Tremblay, G. A., Chen, T., Vogel, G., Morel, M., Cléroux, P., Forget-Richard, A., Komarova, S., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010074 · Cited by 133
Mediero, A., & Cronstein, B. N. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.02.001 · Cited by 133
“They are large, multinucleated cells derived from hematopoietic stem cells [23, 24], and are characterized by high expression of tartrate resistant acid phosphatase (TRAP) and cathepsin K.”
BackgroundTartibian, B., Hajizadeh Maleki, B., Kanaley, J., & Sadeghi, K. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-71 · Cited by 120
“Interleukin (IL) 6, has been shown to promote osteoclast differentiation and activation [8], while tumor necrosis factor (TNF) a, has been shown to stimulate bone resorption and to inhibit bone formation [9].”
BackgroundOsteoclast-derived apoptotic bodies couple bone resorption and formation in bone remodeling
Ma, Q., Liang, M., Wu, Y., Luo, F., Ma, Z., Dong, S., Xu, J., & Dou, C. (2021) · Bone Research · doi:10.1038/s41413-020-00121-1 · Cited by 117
Neural regulation of bone and bone marrow
Maryanovich, M., Takeishi, S., & Frenette, P. S. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031344 · Cited by 114
Ma, Y., Nyman, J. S., Tao, H., Moss, H. H., Yang, X., & Elefteriou, F. (2011) · Endocrinology · doi:10.1210/en.2010-0881 · Cited by 92
PLEKHM1/DEF8/RAB7 complex regulates lysosome positioning and bone homeostasis
Fujiwara, T., Ye, S., Castro-Gomes, T., Winchell, C. G., Andrews, N. W., Voth, D. E., Varughese, K. I., Mackintosh, S. G., Feng, Y., Pavlos, N., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86330 · Cited by 92
Self-citationA bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
Goswami, J., Hernández‐Santos, N., Zuniga, L. A., & Gaffen, S. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200939670 · Cited by 87
“Estrogen deficiency also increases the RANKL:OPG ratio through increases in pro-inflammatory effectors, including IL-1b, IL-6, IL-11, TNF-a, M-CSF and PGE2 [33–35].”
Bone-targeted pH-responsive cerium nanoparticles for anabolic therapy in osteoporosis
Dou, C., Li, J., He, J., Luo, F., Yu, T., Dai, Q., Chen, Y., Xu, J., Yang, X., & Dong, S. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.038 · Cited by 84
“In this period, OC differentiates from mononuclear preosteoclast (pOC) to multinuclear mature OC (mOC) and eventually undergoes apoptosis [8].”
BackgroundRoles of epidermal growth factor family in the regulation of postnatal somatic growth.
Xian, C. J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0049 · Cited by 82
Yun, A. J., & Lee, P. Y. (2004) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00326-8 · Cited by 76
“IL-1, IL-6, TNF-a, GM-CSF, MCSF, and PGE2 have been shown to increase bone resorption through indirect or direct modulation of osteoclasts [3–6].”
BackgroundSphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential
Meshcheryakova, A., Mechtcheriakova, D., & Pietschmann, P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1332180 · Cited by 74
“Given that bone remodeling is known to be associated with substantial loss of osteoblasts by apoptosis (up to 65%) [84], attention was paid to the potential impact of S1P (and LPA) on”
BackgroundEstrogens and Bone Health in Men
Khosla, S., Melton, L. J., & Riggs, B. L. (2001) · Calcified Tissue International · doi:10.1007/s00223-001-1044-8 · Cited by 72
Physiology of the aging bone and mechanisms of action of bisphosphonates
Dominguez, L. J., Di Bella, G., Belvedere, M., & Barbagallo, M. (2011) · Biogerontology · doi:10.1007/s10522-011-9344-5 · Cited by 66
“It has been suggested that BPs may also inhibit apoptosis of osteoblasts and osteocytes ( Manolagas 2000 ).”
BackgroundHadjidakis, D., Tsagarakis, S., Roboti, C., Sfakianakis, M., Iconomidou, V., Raptis, S. A., & Thalassinos, N. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01676.x · Cited by 60
Effects of Doxycycline on Mechanical Properties of Bones in Rats with Ovariectomy-Induced Osteopenia
Pytlik, M., Folwarczna, J., & Janiec, W. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0097-x · Cited by 58
Paller, C. J., Shiels, M. S., Rohrmann, S., Basaria, S., Rifai, N., Nelson, W., Platz, E. A., & Dobs, A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03300.x · Cited by 57
Sadie-Van Gijsen, H., Hough, F. S., & Ferris, W. F. (2013) · Bone · doi:10.1016/j.bone.2013.06.016 · Cited by 48
Sialylation of TLR2 initiates osteoclast fusion
Dou, C., Zhen, G., Dan, Y., Wan, M., Limjunyawong, N., & Cao, X. (2022) · Bone Research · doi:10.1038/s41413-022-00186-0 · Cited by 46
Osteoblasts engulf apoptotic bodies during alveolar bone formation in the rat maxilla
Cerri, P. S. (2005) · The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology · doi:10.1002/ar.a.20220 · Cited by 45
“© 2005 WILEY-LISS, INC. environment; moreover, several systemic hormones and mechanical signals can act on bone cells (Raisz and Rodan, 1998; Manolagas, 2000; Sodek and McKee, 2000).”
BackgroundDecrease in the number and apoptosis of alveolar bone osteoclasts in estrogen‐treated rats
Faloni, A. P. S., Sasso‐Cerri, E., Katchburian, E., & Cerri, P. S. (2007) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2006.00932.x · Cited by 40
Almeida, M., Han, L., O’Brien, C. A., Kousteni, S., & Manolagas, S. C. (2006) · Endocrinology · doi:10.1210/en.2005-1314 · Cited by 40
Self-citation(2007) · PubMed · Cited by 39
Estrogen Deficiency, Postmenopausal Osteoporosis, and Age-Related Bone Loss
Khosla, S., & Pacifici, R. (2013) · Osteoporosis · doi:10.1016/b978-0-12-415853-5.00046-7 · Cited by 31
Ugur‐Altun, B., Altun, A., Arikan, E., Guldiken, S., & Tugrul, A. (2003) · Endocrine Research · doi:10.1081/erc-120026945 · Cited by 22
Zhang, X., Deng, H., Shen, H., & Ehrlich, M. (2021) · JBMR Plus · doi:10.1002/jbm4.10481 · Cited by 20
“Remodeling of cortical bone occurs through complex multicellular units containing ostb and osteoclasts, which modulate each other’s function and are often responsive to some of the same growth factors and cytokines, although sometimes with different responses.((2,16)) Osteocytes (terminally differentiated ostb), which…”
BackgroundBishop, R. T., Miller, A. K., Froid, M., Nerlakanti, N., Li, T., Frieling, J. S., Nasr, M. M., Nyman, K. J., Sudalagunta, P. R., Canevarolo, R. R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46594-0 · Cited by 16
Metabolic regulation by biomaterials in osteoblast
Kang, Z., Wu, B., Zhang, L., Liang, X., Guo, D., Yuan, S., & Xie, D. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1184463 · Cited by 15
“The process of bone remodeling prevents brittle hypermineralized bone accumulation, releases stored calcium and phosphorus, and repairs skeletal damage (Manolagas, 2000; Resch et al., 2022).”
BackgroundJörg, D. J., Fuertinger, D. H., Cherif, A., Bushinsky, D. A., Mermelstein, A., Raimann, J. G., & Kotanko, P. (2022) · eLife · doi:10.7554/elife.76228 · Cited by 15
Metadata
- Authors
- Manolagas, S. C.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2000-04-01
- Volume
- 21
- Issue
- 2
- Pages
- 115-137
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2142820105
- Cited by
- 2,568
- References
- 261
- FWCI
- 26.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.